Ranger International Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$851K Buy
11,735
+1,390
+13% +$93.4K 3.88% 9
2017
Q1
$674 Sell
10,345
-10,345
-50% -$650K 0.04% 47
2016
Q4
$1.3M Sell
20,690
-69,770
-77% -$4.26M 4.18% 8
2016
Q3
$5.71M Sell
90,460
-1,450
-2% -$93.9K 5.66% 2
2016
Q2
$5.69M Buy
+91,910
New +$5.6M 2.41% 22

Other funds holding ABBV

Ranger International Management's ABBV Position: Q2 2017 in Review

Ranger International Management increased its AbbVie (ABBV) stake by 13% in Q2 2017, buying an estimated $93.4K and bringing the position to 11,735 shares worth $851K. The position accounts for 3.88% of the portfolio, ranked #9.

Ranger International Management first reported a position in ABBV in Q2 2016 and has held it in 5 quarters since. The position peaked at $5.71M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Ranger International Management held 11,735 shares of AbbVie worth $851K as of Q2 2017.
  • Ranger International Management bought 1,390 AbbVie shares in Q2 2017, an estimated $93.4K.
  • AbbVie made up 3.88% of Ranger International Management's portfolio in Q2 2017, its #9 holding.
  • Ranger International Management first reported a position in AbbVie in Q2 2016 and has held it in 5 quarters since.
  • Ranger International Management's AbbVie position peaked at $5.71M in Q3 2016.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Ranger International Management's 13F filing for Q2 2017, filed 14 Aug 2017.